Equiniti Group plc buy krebskrebs
Start price
11.01.21
/
50%
€1.28
Target price
11.01.22
€2.50
Performance (%)
57.32%
End price
12.01.22
-
Summary
This prediction is currently being closed. The BUY prediction by krebskrebs for Equiniti Group plc has seen massive gains of 57.32%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Equiniti Group plc | - | - | - | - |
iShares Core DAX® | 0.961% | -2.210% | 12.839% | 17.154% |
iShares Nasdaq 100 | 2.626% | -1.918% | 38.498% | 45.463% |
iShares Nikkei 225® | 0.217% | -7.216% | 19.425% | 5.076% |
iShares S&P 500 | 1.540% | -1.858% | 27.801% | 42.583% |
Comments by krebskrebs for this prediction
In the thread Equiniti Group plc diskutieren
Buy mit Kursziel 2,5
In the thread Trading Equiniti Group plc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten